Source comparison
Best Time Take Melanotan-1 Morning Night: Administration Comparison
Morning (6–9 AM) Mid-morning to early afternoon. Resolves during waking hours, mitigated by movement and hydration Occurs during daytime. Flushing resolves before evening social contexts Suppresses breakfast and lunch appetite. Aligns with lighter meal structu
This comparison does not assign a generated winner or score.
- Morning (6–9 AM)
- Mid-morning to early afternoon. Resolves during waking hours, mitigated by movement and hydration
- Occurs during daytime. Flushing resolves before evening social contexts
- Suppresses breakfast and lunch appetite. Aligns with lighter meal structure for most users
- Peak MC1R responsiveness 2–4 hours post-cortisol rise. Maximises melanogenesis per dose
- Recommended for most protocols. Aligns circadian receptor activity, minimises sleep disruption, allows GI side effects to resolve naturally
- Afternoon (12–3 PM)
- Late afternoon to early evening. Overlaps with dinner preparation, compounds evening fatigue
- Flushing occurs during work hours. May be visible in professional settings
- Suppresses dinner appetite. Creates adherence friction for users who rely on evening meals
- Moderate MC1R responsiveness. Cortisol declining but still elevated above baseline
- Acceptable compromise if morning dosing is impractical. Maintains partial circadian advantage but increases evening nausea risk
- Night (6–10 PM)
- Peaks 90–150 minutes post-injection during sleep onset. Disrupts sleep architecture, worsens reflux when lying flat
- Flushing occurs during sleep. Not visible but does not reduce symptom severity
- Suppresses late-night appetite. Minimal impact if user does not eat after dinner
- Low MC1R responsiveness. Melatonin rise suppresses melanocortin signalling, reducing efficiency per dose
- Not recommended except for users with severe daytime nausea sensitivity. Sacrifices melanogenesis efficiency and increases sleep disruption risk